Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Gentamicin Treatment of Muscular Dystrophy [Phase 1]

View source ↗

Summary

This clinical trial update notes that a Phase 1 study of gentamicin for Becker Muscular Dystrophy and Duchenne Muscular Dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gentamicin (gentamicin)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Becker Muscular Dystrophy, Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED